PGEN

Companies
NASDAQ
Precigen Inc.
Health Care
Price Chart
Overview

About PGEN

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

Market Cap
$408.9M
Volume
3.1M
Avg. Volume
2.3M
P/E Ratio
-6.409091
Dividend Yield
0.00%
Employees
154.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
2.07
High Correlation
Volatility
High (0.87)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Medium Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for PGEN.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, PGEN shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$408.9M
Volume3.1M
P/E Ratio-6.41
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 15, 2025

PortfolioPilot Analysis

Get AI-powered insights on how PGEN fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025